Recent advancements in cancer research highlight breakthrough treatments, including targeted therapy, immunotherapy, and gene therapy. Promising repurposed drugs like ivermectin and fenbendazole are also explored. While these innovations show potential, they must complement established therapies, emphasizing the need for evidence-based approaches and ongoing clinical trials for optimal patient care and outcomes.
